Cryosphere: a frozen home of microbes and a potential source for drug discovery

Sahib Zada1, Mohsin Khan2, Zheng Su1

  • 1Guangzhou Institute of Energy Conversion, Chinese Academy of Sciences, Guangzhou, China.

PubMed

Insights

The cryosphere offers a vast, untapped source of unique microbial compounds for drug discovery. Exploring these cold-adapted microbes can yield novel natural products to combat antibiotic resistance and fulfill new drug demands.

Area of Science:

  • Microbiology
  • Pharmacology
  • Bioprospecting

Background:

  • Emerging pathogens and widespread antibiotic resistance pose significant global health threats.
  • Traditional drug development timelines are insufficient to address these urgent challenges.
  • Natural product drug discovery is crucial for identifying novel therapeutic agents.

Purpose of the Study:

  • To highlight the cryosphere as a novel and underexplored source for microbial drug discovery.
  • To review potential medicinal applications of metabolites from cold-adapted microbes.
  • To discuss challenges and solutions in discovering bioactive compounds from cryospheric environments.

Main Methods:

  • Literature review focusing on cryospheric microbial metabolites and their medicinal potential.
  • Analysis of challenges in cultivating and extracting compounds from extremophilic microorganisms.
  • Exploration of modern approaches for metabolite discovery in cold environments.

Main Results:

  • The cryosphere harbors diverse microbial communities with the potential to produce unique natural products.
  • Cold-adapted microbes yield metabolites with novel chemical scaffolds suitable for drug templates.
  • Overcoming challenges in cold-adapted microbial metabolite discovery is feasible with advanced techniques.

Conclusions:

  • Cryospheric environments represent a promising frontier for bioprospecting novel drug candidates.
  • Developing strategies to harness cryospheric microbial metabolites can address the urgent need for new antibiotics.
  • Modern scientific approaches are key to unlocking the therapeutic potential of cold-adapted microorganisms for drug development.

Related Concept Videos

Cryo-electron Microscopy01:28

Cryo-electron Microscopy

Conventional electron microscopy (EM) involves dehydration, fixation, and staining of biological samples, which distorts the native state of biological molecules and results in several artifacts. Also, the high-energy electron beam damages the sample and makes it difficult to obtain high-resolution images. These issues can be addressed using cryo-EM, which uses frozen samples and gentler electron beams. The technique was developed by Jacques Dubochet, Joachim Frank, and Richard Henderson, for...
3.3K
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.9K
Surface Membrane Barriers01:18

Surface Membrane Barriers

The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
1.1K